FOLFOXIRI or FOLFOXIRI plus bevacizumab as first-line treatment of metastatic colorectal cancer: A propensity score-adjusted analysis from two randomized clinical trials

C. Cremolini, Fotios Loupakis, G. Masi, Sara Lonardi, Cristina Granetto, M. L. Mancini, S. Chiara, R. Moretto, Daniele Rossini, Stefano Vitello, Giacomo Allegrini, Giuseppe Tonini, Francesca Bergamo, Gianluca Tomasello, Monica Ronzoni, Angela Buonadonna, S. Bustreo, Cecilia Barbara, L. Boni, Alfredo Falcone

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'FOLFOXIRI or FOLFOXIRI plus bevacizumab as first-line treatment of metastatic colorectal cancer: A propensity score-adjusted analysis from two randomized clinical trials'. Together they form a unique fingerprint.

Medicine & Life Sciences